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Receptors of the P2X7 type have been demonstrated in
granulocytes, monocytes/macrophages, B and T
lymphocytes, and have been involved in several cellular
mechanisms including those related to inflammation and
immunological response. This study attempted to investigate
the role of these receptors on the inflammatory and
fibrogenic response in the kidneys of unilateral ureteral
obstruction (UUO), by using P2X7 knockout mice (/).
C57Bl6 mice were submitted to left UUO and killed after
7 and 14 days. Histopathology using hematoxylin–eosin,
periodic-acid Schiff and Sirius-red staining,
immunohistochemistry for macrophages, myofibroblasts,
transforming growth factor-b (TGF-b)1 and P2X7, and
immunofluorescence for apoptotic cells (terminal
deoxynucleotidyltransferase-mediated deoxyuridine
triphosphate nick-end labeling) were performed. Protocols
were as follows: (1) control; (2) sham; (3) control P2X7 (/);
(4) sham P2X7 (/); (5) UUO wild type (WT); (6) UUO
P2X7 (/). Myofibroblasts and Sirius-red staining were
significantly lower in UUO P2X7 (/) mice at days 7 and 14,
compared to UUO WT. Kidneys from UUO P2X7 (/) mice
showed reduced number of inflammatory cells at day 14 but
not at day 7, compared to UUO WT. TGF-b1 was less in UUO
P2X7 (/) mice at days 7 and 14 when compared to UUO
WT. Macrophage infiltration and tubular apoptosis were
lower in UUO P2X7 (/) at day 14 but not at day 7,
compared to UUO WT. P2X7 was expressed only in tubular
epithelial cells at day 7 of UUO WT mice. These findings
constitute the first evidence that P2X7 receptors are
implicated in macrophage infiltration, collagen deposition
and apoptosis in response to ureteral obstruction in mice.
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The purinergic P2X7 receptor (P2X7R) is a ligand-gated ion
channel that, like other members of the P2X family, mediates
a non-selective cation conductance when stimulated by an
appropriate ligand.1,2 P2X7R activity is reported to exist in a
limited number of cell types but is readily detectable in cells
of hemopoietic lineage including monocytes, macrophages,
dendritic cells, and lymphocytes.3–6 In 1992, el-Motassium
and Dubyak decribed the activation of phospholipase D
signalling by extracellular adenosine triphosphate (ATP), via
P2X7R in murine macrophages.
7 More recent studies have
shown the role of P2X7R activation on inflammation,
8
elimination of intracellular pathogens,9 and interleukin-1beta
(IL-1b) maturation and release by Schwann cells,10 human
macrophages,11 and upregulation of these receptors in
macrophages during chronic inflammation.12 Several studies
demonstrated that the absence or blocking the P2X7R is
associated with less severe disease outcomes such as chronic
inflammatory and neuropathic pain, and a model of
monoclonal anti-collagen-induced arthritis, indicating that
the P2X7R can function as an integral component of an
in vivo proinflammatory mechanism.13,14
Although the pathophysiology of renal diseases has been
largely explored, only a few studies have addressed the role of
purinergic activation on the mechanism of diseases of the
kidney. A recent study by Vonend et al.15 showed that P2X7
receptors could be upregulated after being challenged by
glomerular injury in disease models of diabetes and
hypertension. Likewise, Solini et al.16 have recently examined
the effects of P2X7 and P2Y on the mesangial matrix
expansion induced by hyperglycemia. In that study the
authors pointed to the importance of P2X7 activation on
transforming growth factor-b (TGF-b) secretion and extra-
cellular matrix production.
Interstitial fibrosis is the end point of most progressive
kidney diseases, leading to loss of renal function. The model
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of unilateral ureteral obstruction (UUO) has been
widely used as an animal model of tubulointerstitial
disease17,18 and it is well established that UUO is associated
with mononuclear infiltration, fibroblast differentiation/
proliferation, increased extracellular matrix protein deposi-
tion and tubule atrophy.19–21 Although many cytokines are
involved in the pathophysiology of UUO, it is well accepted
that TGF-b is one of the most important molecules playing a
major role in the pathogenesis of renal fibrogenesis.22
Macrophages are a major source of this cytokine but its
production by tubular cells may be of importance.23 In this
regard, we have previously investigated the effect of
mycophenolate mofetil, an anti-proliferative drug, to attenu-
ate the progression of inflammation and deposition of
collagen after UUO.24 However, the understanding of
molecular basis of monocyte recruitment and renal fibro-
genesis is still poorly defined. In the present study we
investigated the participation of P2X7R in the development of
renal inflammation and fibrosis after UUO by using wild–-
type (WT) and P2X7 (/) knockout mice.
RESULTS
Description of renal histomorphology
UUO WT and UUO P2X7 (/) animals exhibited a
prominent cortical and medullary atrophy with several
dilated or atrophic tubules (mainly collecting ducts), some
containing apoptotic epithelial cells, which were observed in
all regions. Interstitial space was enlarged, edematous, and
contained inflammatory cells and fibrosis. As can be seen in
Figure 1, UUO P2X7 (/) animals exhibited less renal
interstitial edema and inflammation than UUO WT group
(A and B), and less tubular injury and atrophy (C and D).
Interstitial inflammation was present in both cortex and
medulla and mainly composed of macrophages, which are
more prominent in kidneys from UUO WT group, compared
to group UUO P2X7 (/) (Figure 2a and b). A moderate
amount of collagen, disposed as a loose fibrillary network was
present mainly in medullary atrophic zones but also in the
cortical zones. Figure 2c and d show the higher density of
Sirius-red stained areas in the group UUO WT compared to
the obstructed P2X7 (/) mice.
Renal inflammation
One of the early events in the development of tubulointer-
stitial fibrosis is the recruitment of inflammatory cells.
Hematoxylin–eosin staining of obstructed kidneys suggested
reduced inflammation in P2X7 (/) mice when compared
to WT (Figure 1a and b). Immunohistochemistry for
macrophages using f4/80 antibody confirmed these findings.
The f4/80-positive macrophages were increased after 14 days
in all obstructed WT and P2X7 (/) kidneys when
compared to C and S groups. However, after 14 days of
UUO, P2X7 (/) mice showed 43% less macrophages when
compared to WT (Po0.001). After 7 days, f4/80-positive cells
were 26.2% less in P2X7 (/) group when compared to WT
obstructed mice, although not statistically significant. No
increase in interstitial macrophages was noted in C and S
groups. The values are shown in Tables 1 and 3 and presented
in Figure 3a.
Collagen, myofibroblastic, and TGF-b network
Sirius-red staining showed that collagen was diffusely
increased in the interstitium of obstructed kidneys after 7
and 14 days of UUO. Kidneys from UUO P2X7 (/) mice
exhibited less interstitial collagen, with a significant reduction
of 47.8% at day 7 and 64% at day 14 when compared to the
WT mice, although with higher density compared to C and S
groups (Figure 4a). The values of Sirius-red stained areas are
depicted in Tables 2 and 4.
Myofibroblasts play a central role in the production of
interstitial collagen and development of fibrosis. Their
localization and quantification is one of the most important
events that denote the intensity of fibrogenic stimulus after
UUO. In the obstructed kidneys there was a substantial
amount of a-smooth muscle actin (a-SMA) staining within
the interstitium, predominantly seen in the atrophic areas of
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Figure 1 | Histologic findings of kidney sections after 14 days
of UUO stained by (a and b) hematoxylin–eosin and (c and d)
periodic-acid Schiff, and (e and f) immunofluorescence for
TUNEL. (a), (c), and (e) are from UUO WT mice and (b), (d), and
(f) are from UUO P2X7 (/) mice. (a) Arrows point to increased
cellularity and edema in the interstitium. (c) and (d) Arrows point
to atrophic tubules. (e) and (f) Nuclei are all stained blue with
apoptotic nuclei counterstained fluorescent green and identified
with white arrowheads. Original magnification  40.
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renal medulla. At these regions, a stained fibrillary network
was evidenced throughout the interstitium besides some
peritubular, elongated stained cells (Figure 2e and f). At the
cortex, a-SMA labeling was observed in isolated elongated
cells at peritubular localization. Blood vessels smooth muscle
cells were always reactive. UUO P2X7 (/) mice exhibited
less interstitial a-SMA, with a significant reduction of 62% at
day 14 and 85.7% at day 7 when compared to the WT mice.
The a-SMA staining in P2X7 (/) after 7 days of UUO was
not significantly different when compared to control groups
(Figure 3b) in which a-SMA staining was limited to the blood
vessels smooth muscle cells, with apparently no myofibro-
blasts in the interstitium. All the values are shown in Tables 1
and 3.
TGF-b plays a significant role in the progression of renal
fibrosis in clinical and experimental kidney diseases. In C and
S groups, the kidneys showed uniform homogeneous staining
of TGF-b in the epithelial cells of proximal and distal tubules
and in collecting ducts of cortex. Medullary tubules had only
a patchy distribution of TGF-b staining. There was no
staining in glomeruli, interstitial spaces, or in the paren-
chymal vasculature. After UUO, TGF-b expression increased
significantly and had a uniform distribution within cortical
and medullary tubules. However, the expression in medulla
was not as pronounced as in cortical tubules. Neither
glomerular nor vascular tissue showed TGF-b staining with
obstruction although some interstitial macrophages exhibited
an intense staining. The distribution of TGF-b was similar in
P2X7 (/) and WT mice but the percentage of immuno-
reacting areas in WT mice was significantly higher when
compared to the knockout mice (Figure 2g and h). Values are
shown in Table 1 and presented in Figure 3c.
Tubular atrophy
Tubular atrophy is present as an end point of many kidney
diseases. In the model of UUO, it is generally observed
together with tubule dilation and interstitial collagen
deposition. After 14 days of UUO the number of atrophic
tubules was 7.873.6 per field in WT mice, whereas in P2X7
(/) mice they appeared in a lower number, comprising
approximately 44% less atrophy than the findings in kidney
tissue from UUO WT group (Figure 1c and d). After 7 days
of UUO, however, the reduction of tubular atrophy in P2X7
(/) mice was 31%, and was not significantly different
from WT obstructed mice. Control and sham-operated
animals did not exhibit tubular atrophy. Data are depicted
in Tables 2 and 4 and presented in Figure 4b.
Renal tubular cells apoptosis
Tubular apoptosis was significantly increased in all ob-
structed kidneys when compared to control groups (C and S)
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Figure 2 | (a and b) Immunohistochemical findings from kidney
sections after 14 days of UUO by anti-f4/80, (e and f) anti-a-SMA
(g and h), and anti-TGF-b antibodies. (c and d) show histological
findings with Sirius-red staining. (a), (c), (e), and (g) are UUO
WT mice; (b), (d), (f), and (h) are UUO P2X7 (/) mice. Original
magnification  40.
Table 1 | Results of immunohistochemistry for f4/80, a-SMA, and TGF-b1 at 7 days
C S CKO SKO UUOWT UUOKO
F4/80 1.1571.27 1.4571.28 1.1771.17 1.3771.23 10.3573.35a 7.6072.97b
a-SMA 0.7871.39 1.3972.69 0.7871.39 1.5372.62 7.0875.61a 1.0171.46b
TGF-b1 2.2872.12 2.4172.44 1.7572.00 2.1472.37 8.9176.68a 4.6374.49b
a-SMA, a-smooth muscle actin; C, control; CKO, control knockout; S, sham; SKO, sham knockout; TGF-b1, transforming growth factor-b1; UUOKO, unilateral ureteral
obstruction knockout; UUOWT, unilateral ureteral obstruction wild-type.
Data are mean7s.d. The number of f4/80-positive cells, surface density of a-SMA (%) and surface density of TGF-b were determined in 100 fields as 50 in cortex and 50 in
renal medulla.
aPo0.01 vs all other groups.
bPo0.01 vs C and S.
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Figure 3 | (a) The f4/80-positive cells in renal interstitium, (b) the
a-SMA surface density and, (c) the TGF-b surface density in mice
kidneys after 7 days (&) and 14 days (’) of UUO. (a) *Po0.001 vs
other groups; #Po0.001 vs UUO P2X7 (/) and ##Po0.001 vs other
groups. (b) *Po0.01 vs other groups; #Po0.01 vs UUO P2X7 (/)
and ##Po0.001 vs other groups. (c) *Po0.001 vs UUO P2X7 (/),
**Po0.001 vs other groups; #Po0.001 vs UUO P2X7 (/) and
##Po0.001 vs other groups, by analysis of variance. Values are
mean7s.d.
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Figure 4 | (a) The Sirius-red stained area, (b) the number of
atrophic tubules per field and number of apoptotic cells,
identified by (c) TUNEL technique in mice kidneys after 7 days
(&) and 14 days (’) of UUO. (A) *Po0.001 vs UUO P2X7 (/),
**Po0.001 vs other groups, #Po0.001 vs UUO P2X7 (/) and
##Po0.001 vs other groups. (b) *Po0.001 vs other groups; #Po0.001
vs UUO P2X7 (/) and ##Po0.001 vs other groups. (c) *Po0.001 vs
UUO P2X7 (/), **Po0.001 vs other groups; #Po0.001 vs UUO P2X7
(/) and ##Po0.001 vs other groups by analysis of variance. Values
are mean7s.d.
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at days 7 and 14 after UUO. P2X7 (/) obstructed mice
showed a significant decrease in tubular apoptosis when
compared to WT obstructed mice at days 7 and 14 after
surgery. Tubular apoptosis in the obstructed P2X7 (/)
decreased by 66.7% at days 7 and by 63.7% at day 14 after
UUO, when compared to WT (Po0.001). The data are
exposed in Tables 2 and 4.
Imunohistochemistry for P2X7
C and S groups did not show reactivity for anti-P2X7
antibody in the renal tissue. After 7 days of UUO, WT
animals showed P2X7 staining in epithelial cells only in the
cortex, whereas UUO P2X7 (/) animals did not. After
14 days of UUO, WT, and P2X7 (/) mice did not show
reactivity for the antibody. Control slides (non-immune
serum and blocking peptide) were always negative (Figure 5).
DISCUSSION
Early and the more recent studies from Burnstock25,26
characterized the role of extracellular purinergic agonists
such as ATP, adenosine diphosphate, and adenosine on
different cell types. Studies by Di Virgilio27 and Baraldi,28 and
also a recent review by Burnstock29 emphasized the need
for future trials using P2 receptors antagonists as
anti-inflammatory agents, given the importance of these
receptors as mediators of immunological response. In
particular, the synthesis of cytokines by macrophages,
vascular cell proliferation, and apoptosis, all have been linked
to specific P2X7 receptor activation.
The activation of P2X7 receptors has been documented to
stimulate macrophages phagocytic function. In 1994, Perre-
gaux documented the activation of IL-1b maturation and
release by ATP in mouse macrophages.30 Other studies have
addressed the role of P2 receptor activation, notably the
P2X7, on the mechanisms of immunological and inflamma-
tory response of leukocytes and monocytes/macrophages.31 It
is proposed that these receptors act as regulators of
inflammation, based on their ability to stimulate the release
of cytokines such as IL-1b.31–33 In addition, the activation of
P2X7 receptors enhanced TGF-b1 mRNA expression in type-
2 rat brain astrocytes which demonstrates the possible role of
this receptor in the production of this pro-fibrotic cytokine.34
In the kidney, it has been documented that P2X7 purino-
receptors are expressed at low levels in glomerular mesangial
cells.35 In fact, the studies by Vonend et al.15 and Solini
et al.16 clearly point to a role for P2X7 receptor activation on
macrophage function and matrix formation in the models of
glomerular diseases used. In the study by Vonend et al.,15
Table 2 | Sirius-red density, tubular atrophy, and immunofluorescence for TUNEL at 7 days
C S CKO SKO UUOWT UUOKO
Sirius-red 319.427384.13 349.037340.07 199.207161.02 213.877194.70 2254.8371235.78a 1079.297854.29b
Tubular atrophy 0.070.0 0.070.0 0.070.0 0.070.0 2.3071.48a 1.5970.93b
TUNEL 0.1070.30 0.070.0 0.1870.39 0.1570.36 3.4072.12a 1.1371.11b
C, control; CKO, control knockout; S, sham; SKO, sham knockout; TUNEL, terminal deoxynucleotidyltransferase-mediated deoxyuridine triphosphate nick-end labeling; UUOKO,
unilateral ureteral obstruction knockout; UUOWT, unilateral ureteral obstruction wild type.
Data are mean7s.d. The Sirius-red-stained area (mm2) and the number of atrophic tubules per field were determined in 100 fields as 50 in cortex and 50 in renal medulla.
aPo0.01 vs all other groups.
bPo0.01 vs C and S.
Table 3 | Results of immunohistochemistry for f4/80, a-SMA, and TGF-b1 at 14 days
C S CKO SKO UUOWT UUOKO
F4/80 1.1571.27 1.2870.20 1.7071.90 2.2372.27 68.02720.7a 38.70719.2b
a-SMA 0.7671.46 1.3772.49 0.8071.41 1.5372.04 22.41713.3a 8.3278.34b
TGF-b1 2.0472.44 2.1472.34 1.7071.90 2.2372.27 14.6778.90a 7.0775.78b
a-SMA, a-smooth muscle actin; C, control; CKO, control knockout; S, sham; SKO, sham knockout; TGF-b1, transforming growth factor-b1; UUOKO, unilateral ureteral
obstruction knockout; UUOWT, unilateral ureteral obstruction wild type.
Data are mean7s.d. The number of f4/80-positive cells, surface density of a-SMA (%) and surface density of TGF-b were determined in 100 fields as 50 in cortex and 50 in
renal medulla.
aPo0.01 vs all other groups.
bPo0.01 vs C and S.
Table 4 | Sirius-red density, tubular atrophy, and immunofluorescence for TUNEL at 14 days
C S CKO SKO UUOWT UUOKO
Sirius-red 319.47384.1 349.07340.0 313.367371.12 344.257331.83 3717.172416.8a 1416.871155.6b
Tubular atrophy 0.070.0 0.070.0 0.070.0 0.070.0 7.8173.66a 4,4371,93b
TUNEL 0.1070.30 0.1370.34 0.1870.39 0.1870.39 9.9673.62a 3.671.78b
C, control; CKO, control knockout; S, sham; SKO, sham knockout; TUNEL, terminal deoxynucleotidyltransferase-mediated deoxyuridine triphosphate nick-end labeling; UUOKO,
unilateral ureteral obstruction knockout; UUOWT, unilateral ureteral obstruction wild type.
Data are mean7s.d. The Sirius-red-stained area (mm2) and the number of atrophic tubules per field were determined in 100 fields as 50 in cortex and 50 in renal medulla.
aPo0.01 vs all other groups.
bPo0.01 vs C and S.
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P2X7 receptor is not expressed appreciably under normal
conditions. However, following glomerular injury it is
significantly upregulated, mainly in podocytes, although also
in endothelial and mesangial cells of animals with strepto-
zotocin-induced diabetes mellitus or hypertension in rats
transgenic for the mouse Ren-2 renin gene.
In the present study, using the model of UUO in mice, we
evaluated the role of P2X7 receptor in the process of
interstitial inflammation and fibrosis, tubule atrophy and
renal cells apoptosis in this setting. The results showed that
P2X7 knockout mice did not exhibit the alterations observed
in the WT mice. In the absence of P2X7 receptors, there are
less macrophages in the interstitium, a lower population of
myofibroblasts, diminished collagen deposition, as well as
decreased TGF-b expression in the renal interstitium and less
apoptotic cells. It is noteworthy that the population of
myofibroblasts is profoundly decreased in the kidneys of
knockout mice. These findings suggest that either the
interstitial fibroblasts or other source of myofibroblasts as
epithelial to mesenchimal transition, are somehow stimulated
by purinergic P2X7 activation. Previous studies by Vesey
et al.36,37 demonstrated that IL-1b promotes fibroblast
proliferation and collagen production. It is possible that
these purinergic receptors in macrophages and epithelial cells
are involved in fibroblasts proliferation and matrix formation
in response to cell injury, via activation of IL-1b.
The results from the terminal deoxynucleotidyltransfer-
ase-mediated deoxyuridine triphosphate nick-end labeling
(TUNEL) analysis are in agreement with several studies in
which apoptotic epithelial tubular cell death parallels tubular
atrophy in this model.38,39 The present study demonstrated
that in the absence of P2X7 receptors, the epithelial cells were
less apoptotic, suggesting that the activation of P2X7
receptors may be involved with this process. In fact the role
of P2X7 receptors as inducers of apoptosis of several cell types
is a matter of extensive investigation, being documented in
hematopoietic cells5,40 and rat kidney mesangial cells.35 The
findings on the presence of P2X7 receptors in the kidneys of
obstructed WT mice at day 7 clearly show that these receptors
are being expressed in tubular cells in conditions of
tubulointerstitial injury. To our knowledge, this is the first
documentation of the expression of these receptors in tubular
epithelial cells of obstructed kidneys, as has been described for
mesangial cells in the models of diabetic nephropathy and
hypertension.15,16 Surprisingly, we could not observe its
expression at day 14, in which no positive staining for P2X7
was detected. The explanation for no detection by immuno-
histochemistry at this time point is not apparent at this
moment. One possibility may reside on the increased
apoptotic aspect of the epithelial cells at day 14, with fewer
cells being able to express these receptors. Moreover, we could
not observe positive cells in the interstitium, as no evidence for
macrophages staining at both time points. In fact, Coutinho-
Silva et al.41 have observed a lower expression of P2X7
receptors in pancreatic islets after 8 weeks of streptozotocin-
induced diabetes. The authors suggested that ATP released
could activate lysis of macrophages, if they have high
expression of P2X7. Taken together, these results suggest an
effect of activation of P2X7 receptors, partially contributing to
inflammation and fibrosis of kidney tissue, although expressed
only at an early phase of kidney damage in this model.
In conclusion, the tubulointerstitial damage following
UUO is attenuated in the absence of P2X7 purinergic
receptors, as seen in this study from P2X7 knockout mice.
These results constitute the first evidence for the involvement
of these receptors in the process of interstitial inflammation
and collagen deposition in response to ureteral obstruction.
The effects of P2X7 stimulation in different cell types as
macrophages and tubular epithelial cells, as well as the
mechanisms of action in fibrogenesis need further investiga-
tion. Thus, the potential role of purinergic antagonists as a
tool for novel trials to prevent renal interstitial fibrosis,
should be considered in the near future.
MATERIALS AND METHODS
Animals and experimental protocol
P2X7 (/) mice, initially generated in 129/Ola x C57Bl/6 mice and
then back-crossed for 12 generations to C57Bl/6 mice, have been
described recently9,25 and was kindly provided by Dr James Mobley
(PGRD, Pfizer Inc, Groton, CT, USA). The P2X7 (/) animals had
disruption at the region from T1527 to T1605, located at exon 13.
The WT mice of the same genetic background (C57Bl/6) were used
a
b
Figure 5 | Representative pictures of immunohistochemical study
for anti-P2X7 antibody. (a) P2X7-positive epithelial cells of the
cortex of UUO WT mice at day 7 of obstruction. No positive cells were
detected in the interstitium. (b) Kidney cortex of UUO WT mice at day
14, with no positivity for anti- P2X7.
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as controls. A total of 20 healthy male adult C57Bl/6 mice, 11–13
weeks of age and weighing 30–35 g, underwent left ureteral
obstruction or served as sham operated and control groups. Briefly,
mice were anesthetized intraperitoneally with ketamine (35 mg/kg)
and xylazine (9 mg/kg). Under sterile conditions, an abdominal
midline incision was done; the left ureter exposed and ligated using
4-0 silk in two points. At this step, the ureter was sectioned between
the ligatures. The skin was sutured for approximation and the mice
kept in regular cages. The animals were divided into six groups with
five animals each as follows: (1) control; (2) sham; (3) control P2X7
(/); (4) sham P2X7 (/); (5) UUO WT; (6) UUO P2X7 (/).
Sham-operated animals underwent identical surgical procedures,
except that the left ureter was manipulated without ligation and
sectioning. Control mice underwent no surgical manipulation. Mice
were kept in a 12-h light/dark cycle at 251C and fed a standard rat/
mice chow, and water ad libitum. The animals were killed under
anesthesia, given intraperitoneally, and the kidneys were removed.
All experimental procedures were conducted in accordance with our
institutional guidelines.
Tissue preparation
After 14 days of UUO, mice were killed under anesthesia given
intraperitoneally. Animals were perfused with sterile saline via left
cardiac ventricle, followed by infusion of a 4% buffered parafor-
maldehyde solution for 20 min each. Kidneys were removed,
sectioned mid-frontally into two pieces. One fragment was
immediately fixed overnight in 10% buffered formaldehyde and
other half was conserved in acetone. Samples were dehydrated with
ethanol, treated with xylene and embedded in paraffin at 561C
temperature. Three-micron-thick sections were processed for either
routine staining or immunostaining. For histological evaluation,
sections were stained with hematoxylin–eosin, periodic-acid Schiff
staining for assessment of tubular basement membranes and Sirius-
red staining for collagen detection.
Immunohistochemistry
Interstitial cellularity was characterized and macrophages were
quantified in the cortex and medulla of renal tissue with f4/80 rat
anti-mouse macrophage monoclonal antibody (Serotec Ltd, Oxford,
UK). In addition, the interstitial myofibroblasts were quantified
using a-SMA monoclonal antibody (Dako Corp., Carpinteria, CA,
USA) stained slides. TGF-b was assessed using pan-specific
polyclonal antibody against TGF-b (R&D system Inc., Minneapolis,
MN, USA, Cat: AB-100-NA). Expression and localization of the ATP
receptor P2X7 was characterized by rabbit anti- P2X7 receptor-
purified polyclonal antibody (Alomone, Jerusalem, Israel, cat
number APR-004) staining. Paraffin-embedded sections (3mm)
were cut onto glass slides. The sections were dewaxed in xylene three
times for 15 min, rehydrated in decreasing concentrations of ethanol
for 5 min and washed three times in phosphate-buffered saline for
10 min. Endogenous peroxidase was quenched for 30 min with 0.3%
hydrogen peroxide: methanol solution (v/v). After washing in
distilled water and phosphate-buffered saline a blocking step was
included using either, non-immune serum or 5% bovine serum
albumin in phosphate-buffered saline for a total of 30 min. Primary
antibody against specific antigens described above was then
incubated overnight at 41C in a humidified chamber. Negative
controls were carried out with bovine serum albumin instead of
primary antibody. After achieving room temperature, sections were
washed in 0.25% phosphate-buffered saline-tween solution for
5 min. For f4/80 antibody, biotinylated rabbit anti-rat secondary
antibody (Vector Labs, Burlingame, CA, USA) was incubated for
45 min followed by incubation with avidin–peroxidase complex
(Vector Labs., Burlingame, CA, USA). For a-SMA detection,
monoclonal antibody was biotinylated using the DAKO ARKTM
peroxidase kit (DAKO, cat number K3954). For TGF-b and P2X7
receptor we used Histar 4000 mouse on mouse detection kit
(Serotec, Raleigh, USA). Reactions were revealed using diamino-
benzidine chromogen substrate (Liquid DAB, DAKO cat number
K3466, USA). After washing the slides, counterstaining was done
with Harris hematoxylin for 1 to 2 min.
The quantification of f4/80-positive cells was carried out in a
blinded manner under  40 magnification and expressed as number
of cells per field. Myofibroblast and TGF-b surface density was
obtained by considering the percentage of stained areas in the total
histological fields.
Histomorphometry
Histomorphometry was performed using an imaging analysis system
composed of a digital camera (Coolpix 990, NIKON, Japan) coupled
to a light microscope (Eclipse 400, NIKON, Japan). The images were
captured in a blinded manner in 100 randomized fields (50 of cortex
and 50 of medulla) with a total of 20 fields from each animal, were
used for immunohistochemistry, periodic-acid Schiff and Sirius-red
stained sections. The sections were captured using  40 magnifica-
tion objective lens. The interstitial area of renal cortex and medulla
occupied by collagen was quantified in Sirius-red staining sections
by a point-counting technique described previously.42 All the
quantifications were done by captured high quality images
(2048 1536 pixels buffer) using the Image Pro Plus 4.5.1 (Media
Cybernetics, Silver Spring, MD, USA). A single observer performed
morphological measurement blindly.
Measurement of tubular atrophy
In periodic-acid Schiff-stained sections, the amount of tubular
atrophy was determined as previously described.43 Atrophic tubules
were identified by their thickened and sometimes duplicated
basement membranes, and also by the degree of flattening of the
epithelial cells. The results were presented as the number of atrophic
tubules per field at  40 magnification objective lens.
Detection of apoptosis
Apoptotic cells were detected by TUNEL staining using ApopTag
fluorescent in situ apoptosis detection kit (Chemicon Int. Inc.,
Temecula, CA, USA) according to the manufacturer’s recommenda-
tion. The number of TUNEL-positive cells was counted in a blinded
manner in 60 randomized fields of cortex and medulla, and
expressed as the mean number 7s.d. Representative pictures of
tubular apoptosis are shown in Figure 1.
Statistics
Data are given as mean7s.d. Comparisons between groups were
done by analysis of variance. Post-tests were done using the Tukey
test. The figures were represented by bars. The results were
considered significant when Po0.05.
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